Industry Trend Analysis - Acquisition Bids Highlight Strength Of Stada's Business - 13 MAR 2017
Corporate Financing week March 2017 / Germany / Industry
Potential interest in acquiring Stada Arzneimittel has been building for almost a year, and has now come into the open with these three initial bids. Interest from other firms is certainly a possib...
Industry Trend Analysis - Azaya Acquisition Will Benefit Cytori's Cell Therapy Pipeline - 06 MAR 2017
Corporate Financing week March 2017 / United States / Industry
Cytori's acquisition of Azaya Therapeutics will provide the company with a nanoparticle platform that it can apply to its current pipeline to aid in delivery. The two near-to-market oncology compou...
Industry Trend Analysis - Privatisation Of Local Drugmakers To Enhance Their Competitive Position - 01 AUG 2016
Corporate Financing week July 2016 / Vietnam / Industry
Vietnam's domestic pharmaceutical companies will present a growing competitive threat to multinational firms operating in the South East Asian country. This has been accentuated as the authorities...
Industry Trend Analysis - Medivation Trying To Ignite Bidding War - 25 JULY 2016
Corporate Financing week July 2016 / United States / Industry
A bidding war will likely ensue after Medivation has essentially put itself up for sale. Sanofi could eventually conquer Medivation, but a challenge from Pfizer is probable. Xtandi appears to be...
Industry Trend Analysis - Sagent Acquisition A Logical Next Step For Nichi-Iko - 25 JULY 2016
Corporate Financing week July 2016 / Japan / Industry
Nichi-Iko Pharmaceutical's attention on the US market is a reminder that the US remains by far the largest market in the world for both originator and generic pharmaceuticals. Whilst Japan is the...
Industry Trend Analysis - Lupin On Course To Cement Place In US Market - 14 MAR 2016
Corporate Financing week March 2016 / India / Industry
US FTC consent for Lupin's proposed acquisition of Gavis Pharmaceuticals brings the acquisition a step closer to completion, and with only two products to be divested, the acquisition will be a...
Industry Trend Analysis - Hikma On Track To Boost US Generic Injectables Presence - 07 MAR 2016
Corporate Financing week March 2016 / United States / Industry
Despite the divestitures required by the FTC, Hikma's ongoing acquisition of what was essentially Boehringer Ingelheim's entire generics business will serve to substantially increase Hikma's positi...
Industry Trend Analysis - Expansion Into Asian Emerging Markets To Prove Lucrative - 01 FEB 2016
Corporate Financing week January 2016 / Hungary / Industry
Gedeon Richter's expansion into emerging markets will mitigate any potential risks of loss of sales in the precarious CIS market. It has one of the most extensive gynaecological drug portfolios and...
Industry Trend Analysis - Biotie Acquisition Underscores Acorda's Focus On Parkinson's Need - 01 FEB 2016
Corporate Financing week January 2016 / Finland / Industry
The heavy investment Acorda has made into its Parkinson's pipeline by the acquisition of Biotie will raise concerns over the additional risk bourn by the company. Tozadenant has broad potential in...
Industry Trend Analysis - Pfizer-Allergan Tax Inversion To Close Despite Opposition - 30 NOV 2015
Corporate Financing week November 2015 / United States / Industry
Pfizer's controversial 'tax inversion' of Allergan is likely to close despite bipartisan annoyance at the deal, which will deprive the US Treasury of billions of dollars in taxes over the next few years. It is too late for Congress to pass legislation to prevent such deals before the 2016 presidential election. While the government has the authority to implement retroactive changes to the rules...
READ FULL ARTICLE